Tissue-indepedent cancer drug gets fast-track approval from US regulator

Wednesday, May 24, 2017 - 17:02 in Health & Medicine

Treatment will be given to patients based on a tumour’s molecular markers, rather than its location in the body.Nature News doi: 10.1038/nature.2017.22054

Read the whole article on News @ Nature

More from News @ Nature

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net